Causal inference in paired two-arm experimental studies under
  non-compliance with application to prognosis of myocardial infarction by Bartolucci, F. & Farcomeni, A.
ar
X
iv
:1
21
0.
66
78
v1
  [
ma
th.
ST
]  
24
 O
ct 
20
12
Causal inference in paired two-arm experimental studies
under non-compliance with application to prognosis of
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Abstract
Motivated by a study about prompt coronary angiography in myocardial infarction,
we propose a method to estimate the causal effect of a treatment in two-arm experimental
studies with possible non-compliance in both treatment and control arms. The method is
based on a causal model for repeated binary outcomes (before and after the treatment),
which includes individual covariates and latent variables for the unobserved heterogeneity
between subjects. Moreover, given the type of non-compliance, the model assumes the
existence of three subpopulations of subjects: compliers, never-takers, and always-takers.
The model is estimated by a two-step estimator: at the first step the probability that a
subject belongs to one of the three subpopulations is estimated on the basis of the avail-
able covariates; at the second step the causal effects are estimated through a conditional
logistic method, the implementation of which depends on the results from the first step.
Standard errors for this estimator are computed on the basis of a sandwich formula. The
application shows that prompt coronary angiography in patients with myocardial infarc-
tion may significantly decrease the risk of other events within the next two years, with a
log-odds of about -2. Given that non-compliance is significant for patients being given the
treatment because of high risk conditions, classical estimators fail to detect, or at least
underestimate, this effect.
Key words: Conditional logistic regression; Counterfactuals; Finite mixture models; Latent
variables; Potential outcomes.
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1 Introduction
It is well known that, even in experimental studies, non-compliance is a strong source of con-
founding in the estimation of the causal effect of a treatment, in particular when measured
and/or unmeasured factors affect both the decision to comply and the reaction to the treat-
ment. There are basically three approaches to causal inference in these circumstances. These
are based on: (i) potential outcomes or counterfactuals (e.g., Rubin, 1974, 1978; Holland,
1986; Angrist et al., 1996; Abadie, 2003; Rubin, 2005), (ii) marginal structural models and
inverse probability estimators for these models (Robins, 1989, 1994), or (iii) directed acyclic
graphs (DAGs) formalized by Pearl (1995, 2009). In particular, for two-arm experimental
studies with all-or-nothing compliance1, Bartolucci (2010) developed a method that may be
applied with repeated binary outcomes and is based on an modified version of the condi-
tional logistic estimator (Breslow and Day, 1980; Collett, 1991; Rothaman and Greenland, 1998;
Hosmer and Lemeshow, 2000). This method is based on a DAG model with latent variables,
the parameters of which have a causal interpretation. The same model may be formulated on
the basis of potential outcomes. The estimator is simple to apply, but in the formulation of
Bartolucci (2010) it may be applied when non-compliance is only in the treatment arm and
therefore, using the terminology of Angrist et al. (1996), there are only compliers (who always
comply with the treatment) and never-takers (who never take the treatment regardless of the
assigned arm).
Motivated by an original application about the effectiveness of coronary angiography (CA) in
patients with non-ST elevation acute coronary syndrome, in this paper we extend the approach
of Bartolucci (2010) by considering cases in which non-compliance may be also observed in the
control arm. Therefore, there are three subpopulations: compliers, never-takers, and always-
takers (who always take the treatment regardless of the assigned arm). In particular, we extend
the causal model of Bartolucci (2010) and, basically following the same inferential approach, we
develop a conditional likelihood estimator of the causal effects. The latter may be simply applied.
It is worth noting that these causal effects are measured on the logit scale, given that we are
1all-or-nothing compliance means that the treatment may be taken or not, ruling out partial compliance; for
an approach specifically tailored to partial compliance see Bartolucci and Grilli (2011)
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dealing with binary outcomes; the same scale is used in relevant approaches to causal inference
(e.g., Ten Have et al., 2003; Vansteelandt and Goetghebeur, 2003; Robins and Rotnitzky, 2004;
Vansteelandt and Goetghebeur, 2007). Moreover, as in Bartolucci (2010), the adopted estimator
is based on two steps. At the first step we estimate the probability that a subject is a complier,
a never-taker, or an always-taker on the basis of observable covariates for this subject. At the
second step, the conditional likelihood of a logistic model, based on a suitable design matrix,
which is set up by using the results from the first step, is maximized by a simple Newton-Raphson
algorithm. Given the two-step formulation of the estimator, we use a sandwich formula (White,
1982) for deriving standard errors. These may be used to test the significance of the causal
parameters.
As mentioned above, we develop our methodology in connection with an original study on
CA in patients with non-ST elevation acute coronary syndrome. In particular, we are inter-
ested in investigating whether a prompt CA (within 48h from hospital admission) should be
recommended in light of a lower risk of recurrent cardiovascular events after leaving the hospi-
tal. A prompt CA, together with ECG and other exams performed on patients with coronary
syndrome, may be helpful in better calibrating an in-hospital treatment. Even if the current
guidelines of the European cardiologic society recommend CA within 48h of hospitalization
(Bertrand et al., 2002), in some hospitals patients are submitted to CA only after a few days,
or even not at all. In the cardiology literature a definite recommendation has not yet emerged,
with some studies reporting equivalence of CA performed before or after 48h of hospitalization
(TIMI III B Investigators, 1994; Boden et al., 1998; Mc Cullough et al., 1998), and other stud-
ies reporting superiority of prompt CA (Ragmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators,
1999; Cannon et al., 2001; Fox et al., 2002). In our data, the medium/long term effects of coro-
nary angiography within 48h from hospital admission have been estimated using a control given
by the usual clinical practice in the hospital, which may or may not include the coronary an-
giography; when included, the designed study planned to schedule it only after at least 48h
from hospitalization. Then, subjects assigned to the treatment group are expected to undergo
CA within 48h from hospitalization, whereas patients assigned to the control group may or
may not undergo CA. When a patient in the control group is submitted to CA, the analysis
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is expected to be executed after 48h from the hospitalization. Patients were randomized im-
mediately at hospitalization. In practice, a significant fraction of controls received CA within
48h from hospitalization, possibly due to the need of information in order to promptly proceed
with a treatment. Furthermore, a significant fraction of patients in the active group (treat-
ment arm) did receive CA, but after 48h from hospitalization, possibly due to a busy hospital
schedule which did not allow prompt CA performance. We consequently have a significant non-
compliance in both arms, leading to the presence of never-takers and always-takers in addition
to compliers. Note that non-compliance in this example is more likely a choice of the doctor,
rather than of the patient.
We focus on a relevant group of patients, those arriving at the hospital with myocardial
infarction. From our analyses, based on the causal inference approach here proposed, two
important findings emerge. First of all, there is a significant causal effect of prompt CA, with a
log odds-ratio of about -2 and p-value equal to 0.009. Hence, patients arriving at the hospital
with myocardial infarction should be submitted for coronary angyography within 48h, and this
will help doctors in greatly decreasing the risk of recurrent events after dismissal. Secondly,
we estimate the effects separately on the four groups (never-takers receiving control, compliers
receiving control, compliers receiving treatment, and always-takers receiving treatment), and
we observe that the bias is arising mostly from the always-takers. In fact, the treatment has
substantially no effect on the always-takers, but we estimate a strong effect on compliers.
The paper is organized as follows. In Section 2 we briefly describe the data from the study
motivating this paper. In Section 3 we introduce the causal model for repeated binary response
variables. The proposed two-step estimator is described in Section 4 and its application to
the dataset deriving from the cardiology study outlined above is described in Section 5. Final
conclusions are reported in Section 6.
We implemented the estimator in an R function that we make available to the reader upon
request.
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2 Description of the Prompt Coronary Angiography data
The multicenter trial we consider is based on the inclusion of patients arriving to the hospital
with last episode of angina pectoris within the last 24 hours. The patients were included in the
study if they were diagnosed a myocardial infarction. Patients with persistent ST elevation or
who could not undergo CA were excluded from the study.
The binary response of interest is the recurrence within 2 years after leaving the hospital of
any among: (i) another episode of myocardial infarction, (ii) an episode of angina pectoris of
duration 20 minutes or longer, (iii) other significant cardiovascular events, or (iv) death which
could be related to the current episode. The recorded data concern the presence or absence
of episodes of angina pectoris, myocardial infarction or other cardiovascular events within the
last month before hospitalization, and other covariates. The first can be considered as a pre-
treatment copy of the outcome, which we denote with Y1. Among the covariates there are:
gender, age, smoke, statin use, history of CHD in the family, hypertension, and glicemic index
(GI) at hospitalization. We are interested in investigating the effect of a prompt CA since our
population of patients with myocardial infarction (IMA) at hospitalization could probably be
better treated after CA, and this could prevent further events.
Overall, we have data on n = 1, 560 subjects, whose characteristics are summarized as
follows: there are 63% males, 46% smokers, 75% have a history of CHD in the family, 31%
have hypertension, and 81% use statines regularly. GI has a strongly skewed distribution, with
median equal to 118 and MAD equal to 34; moreover, the mean age is 67.5 with a standard
deviation of 10.8.
Randomization was performed with a proportion of 1:2, and in fact 66% of the patients are
assigned to the prompt CA group. Only 52% of the patients actually were submitted to prompt
CA. There was non-compliance in both groups, with more than 1/3 of the subjects assigned to
each group ending up taking the other treatment. More precisely, 370 subjects assigned to the
prompt CA did undergo CA later than 48h after hospitalization, and 170 patients assigned to
the control group had prompt CA.
Given that after model selection we will conclude that GI and use of statines are predictive
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of compliance (see Section 5), we study these two variables a bit more in depth here. For this
aim, in Table 1 we report the proportion of patients belonging to the groups of not treated
as assigned (assigned and received control), always-takers (assigned to control and received
treatment), never-takers (assigned to treatment and received control), or treated as assigned
(assigned and received treatment), given the level of GI and the use or not of Statines. The level
of GI is discretized on the basis of the quartiles of the empirical distribution. It is important to
underline that the first and last groups are made of both compliers and subjects who were by
chance assigned to the treatment they would have preferred anyway. That is, in the first group
we have both compliers assigned to the control and never-takers randomized to the control; in
the last group we have both compliers assigned to the treatment and always-takers who were
also randomized to the treatment.
GI quartile Use of statines
Arm Group 1st 2nd 3rd 4th No Yes
Control Compliers + never-takers 0.634 0.702 0.674 0.638 0.606 0.676
Always-takers 0.366 0.298 0.326 0.362 0.394 0.324
Treatment Never-takers 0.336 0.335 0.389 0.430 0.443 0.352
Compliers + always-takers 0.664 0.665 0.611 0.570 0.557 0.648
Table 1: Conditional proportion of the group of not treated as assigned (compliers + never-
takers), never-takers, always-takers, or treated as assigned (compliers + alwyas-takers), given
GI and the use or not of statines
From the results in table Table 1 it can be seen that the proportion of never-takers steadily
increases with GI, whereas the proportion of always-takers is larger for the first and last quartiles.
On the other hand, the use of statines seems to increase the compliance in both directions, with
a decrease of 7% of always-takers and 9% of never-takers.
3 The causal model
Let Y1 and Y2 denote the binary outcomes of interest, let V be a vector of observable covariates,
let Z be a binary variable equal to 1 when a subject is assigned to the treatment and to 0
when he/she is assigned to the control, and let X be the corresponding binary variable for the
treatment actually received. In the present framework V and Y1 are pre-treatment variables,
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whereas Y2 is a post-treatment variable. Moreover, non-compliance of the subjects involved
in the experimental study implies that X may differ from Z, since we consider experimental
studies in which subjects randomized to both arms can access the treatment and therefore
any configuration of (Z,X) may be observed. Consequently, we assume the existence of three
subpopulations of subjects enrolled in the study: compliers, never-takers, and always-takers
(Angrist et al., 1996). This rules out the presence of defiers, that is, subjects that systematically
take the treatment if assigned to the control arm and vice-versa.
In the following, we introduce a latent variable model for the analysis of data deriving from
the experimental study described above. This model extends that proposed by Bartolucci (2010)
to deal with two-arm experimental studies of the same type in which, however, non-compliance
may be only observed in the treatment arm. We then derive results about the proposed model
which are useful for making inference on its parameters.
3.1 Model assumptions
We assume that the behavior of a subject depends on the observable covariates V , a latent
variable U representing the effect of unobservable covariates on both response variables, and
a latent variable C representing the attitude to comply with the assigned treatment. The
last one, in particular, is a discrete variable with three possible values: 0 for never-takers, 1
for compliers, and 2 for always-takers. The model is based on assumptions A1-A5 that are
reported below. In formulating these assumptions we use the symbol W1 |= W2|W3 to denote
conditional independence between the random variables W1 and W2 given W3; this notation
naturally extends to random vectors. Moreover, with reference to the variables in our study,
we also let p1(y|u, v) = pr(Y1 = y|U = u,V = v) and p2(y|u, v, c, x) = pr(Y2 = y|U = u,V =
v, C = c,X = x), and by 1{·} we denote the indicator function.
The model assumptions are:
A1: C |= Y1|(U,V );
A2: Z |= (U, Y1, C)|V ;
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A3: X |= (U,V , Y1)|(C,Z) and, with probability 1, X = Z when C = 1 (compliers), X = 0
when C = 0 (never-takers), and X = 1 when C = 2 (always-takers);
A4: Y2 |= (Y1, Z)|(U,V , C,X);
A5: for all u, v, c and x, we have
logit[p2(1|u, v, c, x)]− logit[p1(1|u, v)] = t(c, x)
′β,
where
t(c, x) =


1{c = 0}(1− x)
1{c = 1}(1− x)
1{c = 1}x
1{c = 2}x

 and β =


β0
β1
β2
β3

 .
According to assumption A1 the tendency to comply depends only on (U,V ), whereas
according to assumption A2 the randomization only depends on the observable covariates in V .
This assumption is typically satisfied in randomized experiments of our interest and, in any case,
it may be relaxed by requiring that Z is conditionally independent of U given (V , Y1); this is
shown in Bartolucci (2010). Assumption A3 is rather obvious considering that C represents the
tendency of a subject to comply with the assigned treatment. Assumption A4 implies that there
is no direct effect of Y1 on Y2, since the distribution of the latter depends only on (U,V , C,X);
it also implies an assumption known as exclusion restriction, according to which Z affects Y2
only through X . Finally, assumption A5 states that the distribution of Y2 depends on a vector
of causal parameters β, the elements of which are interpretable as follows:
• β0: effect of control on never-takers;
• β1: effect of control on compliers;
• β2: effect of treatment on compliers;
• β3: effect of treatment on always-takers.
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The most interesting quantity to estimate is the causal effect of the treatment over the
control in the subpopulation of compliers. In the present context, this effect may be defined as
δ = logit[p2(1|u, v, 1, 1)]− logit[p2(1|u, v, 1, 0)] = β2 − β1
and corresponds to the increase of the logit of the probability of success when x goes from 0 to
1, all the other factors remaining unchanged.
The above assumptions imply the dependence structure between the observable and unob-
servable variables may be represented by the same DAG reported in Bartolucci (2010). These
assumptions lead to a causal model in the sense of Pearl (1995) since all the observable and
unobservable factors affecting the response variables of interest are included. Moreover, using
the same approach used in Bartolucci (2010), the model may be also formulated in terms of
potential outcomes, enforcing in this way its causal interpretation.
3.2 Preliminary results
Along the same lines as in Bartolucci (2010), assumptions A1-A5 imply that the probability
function of the conditional distribution of (Y1, Z,X, Y2) given (U,V , C) is equal to
p(y1, z, x, y2|u, v, c) = p1(y1|u, v)q(z|v)f(x|c, z)p2(y2|u, v, c, x),
where q(z|v) = pr(Z = z|V = v) and f(x|c, z) = pr(X = x|C = c, Z = z). After some algebra,
for the conditional distribution of (Y1, Z,X, Y2) given (U,V ) we have
p(y1, z, x, y2|u, v) =
e(y1+y2)λ(u,v)
1 + eλ(u,v)
q(z|v)
2∑
c=0
f(x|c, z)
ey2t(c,x)
′β
1 + eλ(u,v)+t(c,x)′β
π(c|u, v), (1)
where λ(u, v) = logit[p1(y|u, v)] and π(c|u, v) = pr(C = c|U = u,V = v).
This probability function considerably simplifies when x 6= z. In fact, for z = 1 and x = 0,
f(x|c, z) is equal to 1 when c = 0 (never-takers) and to 0 otherwise. Similarly, for z = 0 and
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x = 1, f(x|c, z) is equal to 1 when c = 2 (always-takers) and to 0 otherwise. We then have
p(y1, z, x, y2|u, v) =
e(y1+y2)λ(u,v)
1 + eλ(u,v)
q(z|v)
ey2t(c,x)
′β
1 + eλ(u,v)+t(c,x)′β
π(c|u, v),
with
c =
{
0 if z = 1, x = 0,
2 if z = 0, x = 1.
(2)
Consequently, (Y1, Y2) is conditionally independent of U given (V , Z,X, Y+) and Z 6= X . In
particular, for Y+ = 1 we have
p(y1, y2|u, v, z, x, 1) = p(y1, y2|v, z, x, 1) =
ey2t(c,x)
′β
1 + et(c,x)′β
,
with c defined as in (2).
When x = z, the conditional probability p(y1, z, x, y2|u, v) has the following expression:
p(y1, 0, 0, y2|u, v) =
e(y1+y2)λ(u,v)
1 + eλ(u,v)
q(0|v)
z+1∑
c=z
ey2t(c,0)
′β
1 + eλ(u,v)+t(c,0)′β
π(c|u, v);
note that sum
∑z+1
c=z is extended to c = 0, 1 for x = z = 0 and to c = 1, 2 for x = z = 1.
The latter expression is based on a mixture between the conditional distribution of Y2 for the
population of compliers and that of never-takers.
Finally, consider the conditional distribution of (Y1, Y2) given (U,V , Z,X, Y+), with Y+ =
Y1 + Y2. The probability function of this distribution is denoted by p(y1, y2|u, v, z, x, y+) and is
equal to 1 for y+ = 0, 2, whereas for y+ = 1 it may be obtained as
p(y1, y2|u, v, z, x, 1) =
p(y1, z, x, y2|u, v)
p(1, z, x, 0|u, v) + p(0, z, x, 1|u, v)
.
An interesting result deriving from (1) is that, when x 6= z, the latter expression does not
depend on u and is equal to
p(y1, y2|v, z, x, 1) =
ey2t(x,x)
′β
1 + et(x,x)′β
.
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On the other hand, (Y1, Y2) is no longer conditionally independent of U , given (V, Z,X, Y+)
and X = Z. However, we show below that we can approximate the corresponding conditional
probability function by a function which is independent of u. This is the basis for the pseudo
conditional likelihood estimator of β and δ proposed in the next section.
4 Pseudo conditional likelihood inference
For a sample of n subjects included in the two-arm experimental study, let yi1 denote the
observed value of Y1 for subject i, i = 1, . . . , n, let yi2 denote the value of Y2 for the same
subject, and let vi, zi, and xi denote the corresponding values of V , Z, and X , respectively.
In the following, we introduce an approach for estimating the causal parameter vector β which
closely follows that proposed in Bartolucci (2010). The approach relies on the maximization of
a likelihood based on the probability function p(y1, y2|v, z, x, 1), for the cases in which (Y1, Y2)
is conditionally independent of U given (V, Z,X, Y+), and on an approximated version of this
function otherwise. It results a pseudo conditional likelihood estimator, in the sense of White
(1982), whose main advantage is the simplicity of use; see also Bartolucci and Nigro (2012) for
a related approach applied in a different field. Note that this approach requires the preliminary
estimation of the probability that every subject belongs to one of the three subpopulations
(compliers, never-takers, and always-takers). Overall, the approach is based on two steps that
are detailed in the following.
At the first step we estimate the probabilities that a subject is a never-taker (c = 0), a
complier (c = 1), or an always-taker (c = 2). We assume that a multinomial logit with the
category of compliers as reference category:
log
π(0|v)
π(1|v)
= g(v)′α0, (3)
log
π(2|v)
π(1|v)
= g(v)′α2. (4)
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This implies that
π(0|v) =
exp[g(v)′α0]
1 + exp[g(v)′α0] + exp[g(v)′α2]
, (5)
π(1|v) =
1
1 + exp[g(v)′α0] + exp[g(v)′α2]
, (6)
π(2|v) =
exp[g(v)′α2]
1 + exp[g(v)′α0] + exp[g(v)′α2]
. (7)
Given that the assignment is randomized and does not depend on the individual covariates,
the parameter vectors α0 and α2 are estimated by maximizing the log-likelihood
ℓ1(α0,α2) =
∑
i
ℓ1i(α0,α2),
ℓ1i(α0,α2) = (1− zi)(1− xi) log[π(0|vi) + π(1|vi)] +
∑
i
(1− zi)xi log π(2|vi)
+
∑
i
zi(1− xi) log π(0|vi) +
∑
i
zixi log[π(1|vi) + π(2|vi)].
For this aim, a simple Newton-Raphson algorithm may be used, which is based on the first and
second derivatives of this function. In particular, the first derivative of this function may be
found as follows. First of all we write
ℓ1i(α0,α2) = (1− zi)(1− xi) log
π(0|vi) + π(1|vi)
π(1|vi)
+ (1− zi)xi log
π(2|vi)
π(1|vi)
+ zi(1− xi) log
π(0|vi)
π(1|vi)
+ zixi log
π(1|vi) + π(2|vi)
π(1|vi)
+ n log π(1|vi).
Then, based on the above assumptions (3) and (4), we have
ℓ1i(α0,α2) = (1− zi)(1− xi) log{1 + exp[g(vi)
′α0]}+ (1− zi)xig(vi)
′α2
+ zi(1− xi)g(vi)
′α0 + zixi log{1 + exp[g(vi)
′α2]}
− log{1 + exp[g(vi)
′α0] + exp[g(vi)
′α2]},
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so that
∂ℓ1(α0,α2)
∂α0
=
∑
i
∂ℓ1i(α0,α2)
∂α0
,
∂ℓ1(α0,α2)
∂α0
= [(1− zi)(1− xi)π
∗(0|vi) + zi(1− xi)− π(0|vi)] g(vi),
and
∂ℓ1(α0,α2)
∂α2
=
∑
i
∂ℓ1i(α0,α2)
∂α2
,
∂ℓ1i(α0,α2)
∂α2
= [zixiπ
∗(2|vi) + (1− zi)xi − π(2|vi)]g(vi),
where
π∗(0|vi) =
π(0|vi)
π(0|vi) + π(1|vi)
, π∗(2|vi) =
π(2|vi)
π(1|vi) + π(2|vi)
. (8)
Moreover, regarding the second derivative, we have
∂2ℓ1(α0,α2)
∂α0∂α′0
=
∑
i
{(1− zi)(1− xi)π
∗(0|vi)[1− π
∗(0|vi)]− π(0|vi)[1− π(0|vi)]}g(vi)g(vi)
′,
∂2ℓ1(α0,α2)
∂α0∂α′2
=
∑
i
π(0|vi)π(2|vi)g(vi)g(vi)
′,
∂2ℓ1(α0,α2)
∂α0∂α
′
0
=
∑
i
{zixiπ
∗(2|vi)[1− π
∗(2|vi)]− π(2|vi)[1− π(2|vi)]} g(vi)g(vi)
′.
The estimated parameter vectors, obtained by maximizing ℓ1(α0,α2), are denoted by αˆ0 and
αˆ2 and the corresponding probabilities are denoted by πˆ(0|v), πˆ(1|v), and πˆ(2|v), which are
obtained by (5), (6), and (7), respectively. Finally, by inversion of minus the Hessian matrix,
which is based on the second derivatives above, it is also possible to obtain the standard errors
for the parameter estimates αˆ0 and αˆ2 in the usual way.
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At the second step, we maximize the following weighted conditional log-likelihood:
ℓ2(β|αˆ0, αˆ2) =
∑
i
diℓ2i(β|αˆ0, αˆ2),
ℓ2i(β|αˆ0, αˆ2) = (1− zi)(1− xi)
1∑
c=0
πˆ∗01(c|vi)
exp(yi2βc)
1 + exp(βc)
+ (1− zi)xi
exp(yi2β3)
1 + exp(β3)
+ zi(1− xi)
exp(yi2β0)
1 + exp(β0)
+ zixi
2∑
c=1
πˆ∗12(c|vi)
exp(yi2βc+1)
1 + exp(βc+1)
,
where di = 1{yi1 + yi2 = 1}, so that only discordant configurations are considered, and
ηh =
exp(βh)
1 + exp(βh)
, h = 0, . . . , 3,
where β0 is the effect of placebo on never-takers, β1 is the effect of placebo on compliers, β2 is
the effect of treatment on compliers, and β3 is the effect of treatment of always-takers. Finally,
as generalization of (8), we have that
πˆ∗01(c|vi) =
πˆ(c|vi)
πˆ(0|vi) + πˆ(1|vi)
, c = 0, 1
and
πˆ∗12(c|vi) =
πˆ(c|vi)
πˆ(1|vi) + πˆ(2|vi)
, c = 1, 2.
The first is the probability of being a never-taker or a complier given that the subject is in one of
these subpopulation and his/her covariates; a similar interpretation holds for the probabilities
of the second type.
In order to compute the first and second derivatives of ℓ2(β|αˆ0, αˆ2) with respect to β, it is
convenient to express i-th component of this function as
ℓ∗2i(η|αˆ0, αˆ2) = yi2 log(wˆ
′
iη) + (1− yi2) log(1− wˆ
′
iη),
where η = (η0, η1, η2, η3)
′ and the vector of wˆi is defined as follows depending on zi, xi and the
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estimates from the first step:
wˆi =


(πˆ∗01(0|vi), πˆ
∗
01(1|vi), 0, 0)
′, if zi = xi = 0,
(0, 0, 0, 1)′, if zi = 0, xi = 1,
(1, 0, 0, 0)′, if zi = 1, xi = 0,
(0, 0, πˆ∗12(1|vi), πˆ
∗
12(2|vi))
′, if zi = xi = 1.
Then we have the following first derivative:
∂ℓ2(β|αˆ0, αˆ2)
∂β
=
∑
i
di
∂ℓ2i(β|αˆ0, αˆ2)
∂β
,
∂ℓ2i(β|αˆ0, αˆ2)
∂β
= diag(a)
∂ℓ∗2i(η|α0,α2)
∂η
,
where a = diag(η)(1 − η), with 1 denoting a column vector of ones of suitable dimension.
Similarly, with
∂2ℓ∗2(η|αˆ0, αˆ2)
∂η∂η′
= −
∑
i
di
[
yi2
(wˆ′iη)
2
+
1− yi2
(1− wˆ′iη)
2
]
wˆiwˆ
′
i.
we have that
∂2ℓ2(β|αˆ0, αˆ2)
∂β∂β′
= diag(a)
∂2ℓ∗2(η|αˆ0, αˆ2)
∂η∂η′
diag(a) + diag(b)diag
(
∂ℓ∗2(η|αˆ0, αˆ2)
∂η
)
,
where b = diag(a)(1− 2η).
In order to compute standard errors for the parameter estimates, we use a sandwich formula
for estimating the variance-covariance matrix of the overall estimator θˆ = (α′0,α
′
1,β)
′. In
particular, we have
Σˆ = Hˆ
−1
KˆHˆ
−1
,
where the matrices Hˆ and Kˆ are defined in Appendix.
Along the same lines as in Bartolucci (2010) we have performed a simulation study about
the performance of the proposed estimator which we do not show here for reasons of space.
Our simulation study suggests good finite sample properties of the estimator, also under more
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general assumptions than those formulated in Section 3. Furthermore, it can be shown that if
the control has the same effect on never-takers and compliers, and the treatment has the same
effect on compliers and always-takers, the estimator βˆ is consistent as n grows to infinity, in
symbols βˆ
p
→ β¯, with β¯ = (β¯0, β¯1, β¯2, β¯3)
′ denoting the true parameter vector.
The result on existence and consistency of the estimators is not ensured to hold when
β¯0 6= β¯1 and/or β¯2 6= β¯3. However, from the results of White (1982) on the maximum like-
lihood estimation of misspecified models, it derives that βˆ
p
→ β
∗
, where β
∗
is the supremum of
E{ℓ2(β|α0∗,α2∗)/n}. In the previous expression, α0∗ and α2∗ denote the limit in probability
of αˆ0 and αˆ2, respectively. We therefore expect β∗ to be close to β¯ when β¯0 is close to β¯1, β¯2
is close to β¯3, and π(c|u, v) weakly depends on u. The same may be said about the estimator δˆ
of δ, whose limit in probability is denoted by δ∗ and may be directly computed from β∗.
5 Application to randomized study on coronary angiog-
raphy after myocardial infarction
In this section we describe the application of the proposed estimator to the analysis of the
data described in Section 2. We recall that the proposed approach is based on two steps: (i)
estimation of the model for probability of being a never-taker, a complier, or an always-taker,
and (ii) computation of the approximate conditional logistic estimator.
Regarding the first step, an important point is the selection of the covariates to explain the
non-compliance. In particular, we performed model choice by minimizing the Bayesian Infor-
mation Criterion (BIC, see Schwarz, 1978), and finally selected two predictors (GI discretized
using the quartiles and use of statines); see also Section 2. The results from fitting this model
are reported in Table 2 in terms of estimates of the parameters α0 and α2, which are involved in
expressions (3) and (4), and corresponding t-statistics and p-values. For the categorical variable
identifying the quartile of GI, we used the last quartile as reference category.
We observe a significant non-compliance. The probabilities of being an always or a never
taker are related in both cases with the GI and with use of statines. It can be seen that there is
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Parameter estimates for probability of being never-taker
Estimator Value Std. Err. t-statistic p-value
αˆ00 (Intercept) 1.604 0.531 3.017 0.002
αˆ01 (1st quartile GI) -0.757 0.384 -1.974 0.048
αˆ02 (2nd quartile GI) -0.886 0.368 -2.406 0.016
αˆ03 (3rd quartile GI) -0.437 0.388 -1.125 0.260
αˆ04 (use of statin) -0.985 0.438 -2.247 0.025
Parameter estimates for probability of being always-taker
Estimator Value Std. Err. t-statistic p-value
αˆ20 (Intercept) 1.454 0.597 2.436 0.015
αˆ21 (1st quartile GI) -0.565 0.444 -1.274 0.202
αˆ22 (2nd quartile GI) -0.862 0.434 -1.987 0.046
αˆ23 (3rd quartile GI) -0.459 0.449 -1.023 0.306
αˆ24 (use of statin) -0.980 0.496 -1.977 0.048
Table 2: Estimates of compliance probability parameters for the proposed model, computed on
the prompt coronary angiography data; predictors are quartiles of glicemic index (GI) and use
of statines.
a significant lower probability of being a always-taker in the second GI quartile with respect to
the fourth, while the other two quartiles are not statistically different from the fourth. On the
other hand, the probability of being a never taker steadily increases with the GI category, with
the third and fourth quartile not being significantly different. The estimated effects of GI for
always-takers are explained considering that doctors may choose to assign to prompt CA even
patients randomized to the control (therefore making them always-takers) with an abnormal GI
(here, above the median or in the first quartile). Finally, the use of statines increases compliance
in both directions. This effect can be related to the fact that patients using statines are better
monitored and maybe already known to doctors, and therefore an higher adherence to the
experimental settings is easier for these patients.
Note that, even without covariates, by the proposed method we can obtain an approximately
unbiased estimator of the causal effect (as seen by comparing δˆ with δˆ(1) in Table 3), but the
use of covariates allows to take into account part of the heterogeneity, therefore decreasing the
standard error of this estimate.
In Table 3 we report estimates of causal parameters, and compare them with four other
estimators. The first (denoted by δˆ(1)) is based on our proposed approach in which no covariates
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Estimates of the causal parameters
Estimator Value Std. Err. t-statistic p-value
βˆ0 2.158 0.361 5.973 < 0.001
βˆ1 1.948 0.677 2.878 0.004
βˆ2 -0.072 0.370 -0.195 0.845
βˆ3 2.252 0.455 4.945 < 0.001
Estimates of the causal effect for compliers
Estimator Value Std. Err. t-statistic p-value
δˆ (proposed method) -2.020 0.769 -2.625 0.009
δˆ(1) (proposed method) -1.938 0.929 -2.086 0.037
δˆ(2) -0.177 0.118 -1.500 0.133
δˆ(3) -0.513 0.119 -4.311 < 0.001
δˆ(4) -0.550 0.149 -3.691 < 0.001
Table 3: Causal parameters for the proposed model estimated on the prompt coronary angiogra-
phy data. Predictors are GI (discretized in quartiles) and use of statines. In the bottom panel,
δˆ is compared with the same estimate when covariates are not used (δˆ(1)) and with competing
estimators: δˆ(2) standard conditional estimator based on received treatment (X); δˆ(3) standard
conditional estimator based on assigned treatment (Z, Intention to Treat analysis); δˆ(4) standard
conditional estimator based on the assigned and complied treatment (Per Protocol analysis)
are used to predict compliance. The other three estimators (denoted by δˆ(2), δˆ(3), and δˆ(4),
respectively) are based on conditional logistic regression on the received treatment, an Intention
to Treat and a Per Protocol analysis. The last two are based on the assigned treatment regardless
of the actually received treatment, and on patients actually receiving the assigned treatment,
respectively. From the upper panel we can see that the control has approximately the same
effect on never takers and on compliers (with a log-odds of about 2). The treatment seems to
have no effect on compliers, while on always-takers we once again obtain a log-odds of about
2. We therefore can say that (i) lack of a prompt CA, regardless of whether it was assigned or
as a result of non-compliance, may increase the risk of recurrence and (ii) if a patient who was
assigned to the control group undergoes prompt CA, this is likely due to a possibly bad (even
life threatening) condition, hence the high risk of recurrent events even under the treatment. A
consequence is that bias with ITT and PP estimators arise mostly due to always takers. In fact,
the effect of the control is approximately the same on never-takers and compliers (β0 ≈ β1); on
the other hand, there is a strong difference of the effect of treatment as estimated on compliers
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and always-takers (β2 6= β3).
Always-takers in this example can be expected to experience the event even after the treat-
ment. Ignoring this fact will make the two groups artificially more similar, as testified by the
estimates δˆ(2), δˆ(3), and δˆ(4). In fact, our most important estimate is δˆ, which is approximately
−2. When our final estimate is compared with δˆ(2), δˆ(3), and δˆ(4) we find that those are at
most only half our causal estimate. The estimate of the causal parameter based on the re-
ceived treatment (δˆ(2)) is not even significant. Standard fits in this example may lead to grossly
underestimate the effect of a prompt CA.
6 Discussion
An approach has been introduced to estimate the causal effect of a treatment over control on the
basis of a two-arm experimental study with possible non-compliance. The approach is applicable
when the effect of the treatment is measured by a binary response variable observed before and
after the treatment. It relies on a causal model formulated on the basis of latent variables for
the effect of unobservable covariates at both occasions and to account for the difference between
compliers and non-compliers in terms of reaction to control and treatment. The parameters of
the model are estimated by a pseudo conditional likelihood approach based on an approximated
version of the conditional probability of the two response variables given their sum. The causal
model and the proposed estimator extend the model and the estimator of Bartolucci (2010) to
the case in which non-compliance may also happen in the control arm.
The method is applied to the analysis of data coming from a study on the effect of prompt
coronary angiography in myocardial infarction. The application shows that prompt coronary
angiography in patients with myocardial infarction may significantly decrease the risk of other
events within the next two years, with a log-odds of about -2. On the other hand, estimates of
this log-odds ratio obtained by the standard logistic approach are considerably closer to 0.
One of the basic assumptions on which the approach relies is that a subject is assigned to
the control arm or to the treatment arm with a probability depending only on the observable
covariates and not on the pre-treatment response variable. Indeed, we could relax this assump-
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tion, but we would have much more complex expressions for the conditional probability of the
response variables given their sum.
As a final comment we remark that we only considered the case of repeated response vari-
ables having a binary nature. However, the approach may be directly extended to the case
of response variables having a different nature (e.g. counting), provided that the conditional
distribution of these variables belongs to the natural exponential family and the causal effect is
measured on a scale defined according to the canonical link function for the adopted distribution
(McCullagh and Nelder, 1989).
Appendix: Matrices involved in the sandwich estimator for the vari-
ance of the estimator
We have that
Hˆ =


∂ℓ1(αˆ0, αˆ2)
∂α0∂α
′
0
∂ℓ1(α0,α2)
∂α0∂α
′
2
O
∂ℓ1(α0,α2)
∂α2∂α′0
∂ℓ1(α0,α2)
∂α2∂α′2
O
∂ℓ2(β|αˆ0, αˆ2)
∂β∂α′0
∂ℓ2(β|αˆ0, αˆ2)
∂β∂α′2
∂ℓ2(β|αˆ0, αˆ2)
∂β∂β′


and
Kˆ =
∑
i


∂ℓ1i(αˆ0)
∂α0
∂ℓ1i(αˆ2)
∂α2
∂ℓ2i(βˆ|αˆ0, αˆ2)
∂β


( ∂ℓ1i(αˆ0)
∂α′0
∂ℓ1i(αˆ2)
∂α′2
∂ℓ2i(βˆ|αˆ0, αˆ2)
∂β′
)
.
In the above expressions, O denotes a matrix of zeros of suitable dimension. Moreover, all the
derivatives have been defined, with the exception of the derivative of ℓ2(βˆ|αˆ0, αˆ2) with respect
to α0 (or α2) and β. In particular, we have that:
∂2ℓ∗2(β|αˆ0, αˆ2)
∂β∂α′c
= diag(aˆ)
∑
i
di
(
yi2
wˆ′iη
−
1− yi2
1− wˆ′iη
)
∂wˆi
∂α′c
, c = 0, 2,
where
∂wˆi
∂α′0
=
{
(πˆ∗01(0|vi)πˆ
∗
01(1|vi),−πˆ
∗
01(0|vi)πˆ
∗
01(1|vi), 0, 0)
′g(vi), zi = xi = 0,
O, otherwise,
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and
∂wˆi
∂α′0
=
{
(0, 0,−πˆ∗12(1|vi)πˆ
∗
01(1|vi), πˆ
∗
12(1|vi)πˆ
∗
12(2|vi))
′g(vi), zi = xi = 1,
O, otherwise.
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